Cargando…

Evaluation of the Antinociceptive Effect of Maropitant, a Neurokinin-1 Receptor Antagonist, in Cats Undergoing Ovariohysterectomy

Maropitant is a neurokinin-1 (NK1) receptor antagonist that can be used for pain management. The objective of this study was to evaluate the effect of continuous infusion of two doses of maropitant on cardiorespiratory parameters and its postoperative analgesic effect in cats undergoing ovariohyster...

Descripción completa

Detalles Bibliográficos
Autores principales: Corrêa, Janaina M. X., Soares, Priscila C. L. R., Niella, Raquel V., Costa, Brenda A., Ferreira, Maxuel S., Junior, Alex C. Silva, Sena, Aline S., Sampaio, Kátia M. O. R., Silva, Elisângela B., Silva, Fabiana L., Lavor, Mário S. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476118/
https://www.ncbi.nlm.nih.gov/pubmed/31093325
http://dx.doi.org/10.1155/2019/9352528
_version_ 1783412850170003456
author Corrêa, Janaina M. X.
Soares, Priscila C. L. R.
Niella, Raquel V.
Costa, Brenda A.
Ferreira, Maxuel S.
Junior, Alex C. Silva
Sena, Aline S.
Sampaio, Kátia M. O. R.
Silva, Elisângela B.
Silva, Fabiana L.
Lavor, Mário S. L.
author_facet Corrêa, Janaina M. X.
Soares, Priscila C. L. R.
Niella, Raquel V.
Costa, Brenda A.
Ferreira, Maxuel S.
Junior, Alex C. Silva
Sena, Aline S.
Sampaio, Kátia M. O. R.
Silva, Elisângela B.
Silva, Fabiana L.
Lavor, Mário S. L.
author_sort Corrêa, Janaina M. X.
collection PubMed
description Maropitant is a neurokinin-1 (NK1) receptor antagonist that can be used for pain management. The objective of this study was to evaluate the effect of continuous infusion of two doses of maropitant on cardiorespiratory parameters and its postoperative analgesic effect in cats undergoing ovariohysterectomy. Thirty cats were randomly assigned to one of three groups (10 cats each group): the control group (CG) received a continuous infusion of 10 ml/kg/h Ringer's lactate; GM30 and GM100 first received an intravenous (IV) bolus of 1 mg/kg maropitant; GM30 then received continuous infusion of 30 μg/kg/h maropitant; and GM100 then received continuous infusion of 100 μg/kg/h maropitant. The maropitant was diluted into Ringer's lactate and the GM30 and GM100 also received fluids intraoperatively. In all groups, premedication included intramuscular injections of morphine and acepromazine, followed by induction with propofol and maintenance with isoflurane. Temperature, heart rate (HR), Doppler blood pressure (DBP), respiratory rate, oxygen saturation, and measuring the end-tidal carbon dioxide and isoflurane were monitored. Postoperative pain was evaluated using a visual analog scale and the UNESP-Botucatu multidimensional composite pain scale in cats; morphine was used for analgesic rescue. During the surgical procedure, cats in GM100 demonstrated lower HR and DBP than those in CG. With regard to the evaluation of postoperative pain, GM100 required the least frequent morphine rescue and less rescue analgesia compared with CG. In conclusion, cats in GM100 maintained lower DBP and HR and required lower analgesic rescue during the postoperative period. The results suggested that animals receiving maropitant bolus (1 mg/kg) plus (100 μg/kg/h) experienced greater postoperative comfort, reflected by the lesser need for analgesic rescue. The use of maropitant in surgical procedures in cats contributes to postoperative comfort.
format Online
Article
Text
id pubmed-6476118
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-64761182019-05-15 Evaluation of the Antinociceptive Effect of Maropitant, a Neurokinin-1 Receptor Antagonist, in Cats Undergoing Ovariohysterectomy Corrêa, Janaina M. X. Soares, Priscila C. L. R. Niella, Raquel V. Costa, Brenda A. Ferreira, Maxuel S. Junior, Alex C. Silva Sena, Aline S. Sampaio, Kátia M. O. R. Silva, Elisângela B. Silva, Fabiana L. Lavor, Mário S. L. Vet Med Int Research Article Maropitant is a neurokinin-1 (NK1) receptor antagonist that can be used for pain management. The objective of this study was to evaluate the effect of continuous infusion of two doses of maropitant on cardiorespiratory parameters and its postoperative analgesic effect in cats undergoing ovariohysterectomy. Thirty cats were randomly assigned to one of three groups (10 cats each group): the control group (CG) received a continuous infusion of 10 ml/kg/h Ringer's lactate; GM30 and GM100 first received an intravenous (IV) bolus of 1 mg/kg maropitant; GM30 then received continuous infusion of 30 μg/kg/h maropitant; and GM100 then received continuous infusion of 100 μg/kg/h maropitant. The maropitant was diluted into Ringer's lactate and the GM30 and GM100 also received fluids intraoperatively. In all groups, premedication included intramuscular injections of morphine and acepromazine, followed by induction with propofol and maintenance with isoflurane. Temperature, heart rate (HR), Doppler blood pressure (DBP), respiratory rate, oxygen saturation, and measuring the end-tidal carbon dioxide and isoflurane were monitored. Postoperative pain was evaluated using a visual analog scale and the UNESP-Botucatu multidimensional composite pain scale in cats; morphine was used for analgesic rescue. During the surgical procedure, cats in GM100 demonstrated lower HR and DBP than those in CG. With regard to the evaluation of postoperative pain, GM100 required the least frequent morphine rescue and less rescue analgesia compared with CG. In conclusion, cats in GM100 maintained lower DBP and HR and required lower analgesic rescue during the postoperative period. The results suggested that animals receiving maropitant bolus (1 mg/kg) plus (100 μg/kg/h) experienced greater postoperative comfort, reflected by the lesser need for analgesic rescue. The use of maropitant in surgical procedures in cats contributes to postoperative comfort. Hindawi 2019-04-08 /pmc/articles/PMC6476118/ /pubmed/31093325 http://dx.doi.org/10.1155/2019/9352528 Text en Copyright © 2019 Janaina M. X. Corrêa et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Corrêa, Janaina M. X.
Soares, Priscila C. L. R.
Niella, Raquel V.
Costa, Brenda A.
Ferreira, Maxuel S.
Junior, Alex C. Silva
Sena, Aline S.
Sampaio, Kátia M. O. R.
Silva, Elisângela B.
Silva, Fabiana L.
Lavor, Mário S. L.
Evaluation of the Antinociceptive Effect of Maropitant, a Neurokinin-1 Receptor Antagonist, in Cats Undergoing Ovariohysterectomy
title Evaluation of the Antinociceptive Effect of Maropitant, a Neurokinin-1 Receptor Antagonist, in Cats Undergoing Ovariohysterectomy
title_full Evaluation of the Antinociceptive Effect of Maropitant, a Neurokinin-1 Receptor Antagonist, in Cats Undergoing Ovariohysterectomy
title_fullStr Evaluation of the Antinociceptive Effect of Maropitant, a Neurokinin-1 Receptor Antagonist, in Cats Undergoing Ovariohysterectomy
title_full_unstemmed Evaluation of the Antinociceptive Effect of Maropitant, a Neurokinin-1 Receptor Antagonist, in Cats Undergoing Ovariohysterectomy
title_short Evaluation of the Antinociceptive Effect of Maropitant, a Neurokinin-1 Receptor Antagonist, in Cats Undergoing Ovariohysterectomy
title_sort evaluation of the antinociceptive effect of maropitant, a neurokinin-1 receptor antagonist, in cats undergoing ovariohysterectomy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476118/
https://www.ncbi.nlm.nih.gov/pubmed/31093325
http://dx.doi.org/10.1155/2019/9352528
work_keys_str_mv AT correajanainamx evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy
AT soarespriscilaclr evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy
AT niellaraquelv evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy
AT costabrendaa evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy
AT ferreiramaxuels evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy
AT junioralexcsilva evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy
AT senaalines evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy
AT sampaiokatiamor evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy
AT silvaelisangelab evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy
AT silvafabianal evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy
AT lavormariosl evaluationoftheantinociceptiveeffectofmaropitantaneurokinin1receptorantagonistincatsundergoingovariohysterectomy